Cowingene Enterovirus Detection Kit (NATBox) for Rapid Point-of-Care Molecular Diagnosis

Enterovirus infections continue to be a significant global health challenge, particularly in pediatric populations where outbreaks can spread rapidly through communities. Early and accurate detection is essential for effective clinical management, infection control, and timely public health response. Molecular diagnostic technologies have therefore become a critical tool in modern infectious disease control.

Cowin Gene is dedicated to advancing molecular POCT (Point-of-Care Testing) technology by providing clinicians and patients with rapid, easy-to-use, and highly sensitive diagnostic solutions. Its PCR-based core product line enables fast detection of a wide range of pathogens, including viruses, bacteria, and fungi, significantly improving diagnostic efficiency in clinical and field environments.

With a strong team of senior scientists, engineers, and marketing experts, Cowin Gene continuously focuses on technological innovation and product optimization. Its R&D center is equipped with advanced laboratory instruments and operates under a strict quality management system to ensure that every product meets international in vitro diagnostic standards. The company aims to become a global leader in molecular POCT, delivering fast and reliable diagnostic solutions to improve healthcare outcomes worldwide.

Cowingene Enterovirus Detection Kit (NATBox) for Rapid Point-of-Care Molecular Diagnosis

The Cowingene Enterovirus Detection Kit (NATBox) is an in vitro diagnostic (IVD) assay designed for the qualitative detection of Enterovirus RNA in clinical specimens. It utilizes real-time PCR technology integrated within the NATBox system to deliver fast and accurate molecular diagnostic results.

This kit is specifically designed for point-of-care environments, allowing healthcare professionals to perform testing outside traditional centralized laboratories. Its streamlined workflow significantly reduces manual handling steps, minimizing contamination risk and improving operational efficiency.

With a detection limit of 400 copies/mL, the kit ensures high sensitivity even in early-stage infections or low viral load samples. This makes it highly effective for rapid screening and outbreak monitoring.

Integrated NATBox System Enterovirus Detection Kit for Fast and Accurate Testing

This integrated NATBox system kit is designed to simplify the molecular diagnostic process by combining sample preparation, amplification, and detection into a single compact workflow. It eliminates the need for complex laboratory infrastructure and reduces dependence on highly trained technicians.

The system is compatible with the NATBox® Mini II instrument, enabling automated and standardized testing procedures. This ensures consistent performance and reliable results across different testing environments.

The kit supports the detection of Enterovirus RNA in human stool and vomitus samples, making it particularly suitable for gastrointestinal infection diagnosis. Its closed system design enhances biosafety and reduces the risk of cross-contamination.

Portable Cowingene NATBox Enterovirus Detection Kit for Clinical and Field Use

The portable design of the NATBox Enterovirus Detection Kit makes it highly suitable for both clinical laboratories and field-based diagnostic applications. Its compact system allows rapid deployment in hospitals, emergency centers, and remote healthcare facilities.

The reagent system is designed for easy operation, with simplified steps including lysis buffer addition and cartridge-based processing. Once prepared, the cartridge should be used within 30 minutes to ensure optimal performance and accuracy.

Storage at 2–8°C for up to 12 months provides excellent stability, while transport under the same conditions for up to 15 days ensures logistical flexibility for global distribution.

High-Efficiency NATBox Enterovirus Molecular Diagnostic Kit for Reliable RNA Detection

This high-efficiency NATBox molecular diagnostic kit is engineered to deliver reliable RNA detection with minimal operational complexity. It integrates advanced PCR amplification technology with a closed-cartridge system to ensure rapid and accurate results.

The kit includes strict handling requirements to maintain reagent stability and performance. Once opened, key components such as lysis buffer, positive control, and negative control can be stored at 2–8°C for up to one month. After adding lysis buffer, cartridges should be used within 30 minutes to ensure optimal test accuracy.

The system also requires proper temperature equilibration before use, ensuring consistent reagent activation and reliable amplification performance.

Cowin Gene’s molecular POCT products provide significant advantages in clinical diagnostics, including rapid detection time, simplified operation procedures, and high sensitivity performance. These features make them highly suitable for hospitals, outpatient clinics, emergency departments, and field testing scenarios.

The company’s core product line is based on PCR technology, enabling rapid detection of multiple pathogen types such as viruses, bacteria, and fungi. Each product is developed under a strict quality management system to ensure compliance with international in vitro diagnostic standards.

The Cowingene Enterovirus Detection Kit (NATBox) is supported by essential auxiliary reagents, including sample diluent solutions and the NATBox system platform, ensuring a complete and optimized workflow from sample processing to final detection.

Cowin Gene continues to invest heavily in research and development, driving innovation in molecular POCT technology. With a vision to become a global innovation leader in in vitro diagnostics, the company is committed to delivering fast, reliable, and accessible diagnostic solutions that improve global healthcare and support effective infectious disease control worldwide.